Quadrant Capital Group LLC Inovio Pharmaceuticals, Inc. Transaction History

Quadrant Capital Group LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.79 - $1.91 $3,641 - $8,803	-4,609 Reduced 35.66%	8,316 $6,000
Q4 2022 Feb 10, 2023	BUY	$1.41 - $2.5 $13,533 - $23,995	9,598 Added 288.49%	12,925 $20,000
Q3 2022 Nov 10, 2022	BUY	$1.66 - $2.79 $5,522 - $9,282	3,327 New	3,327 $6,000
Q4 2021 Feb 01, 2022	SELL	$4.99 - $7.46 $1,716 - $2,566	-344 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $136 - $184	19 Added 5.85%	344 $2,000
Q2 2021 Aug 09, 2021	BUY	$6.23 - $10.03 $2,024 - $3,259	325 New	325 $3,000
Q1 2021 May 12, 2021	SELL	$8.81 - $16.96 $1,242 - $2,391	-141 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $1,198 - $1,811	141 New	141 $1,000
Q2 2020 Aug 13, 2020	SELL	$7.14 - $31.69 $549 - $2,440	-77 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $229 - $1,084	77 New	77 $1,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $476M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

Stay updated on Quadrant Capital Group LLC with notifications on news.